Answers are grounded in this paper and cite their sources.
Background Conduction system pacing (CSP), including His bundle pacing (HBP) and left bundle branch pacing (LBBP) are emerging pacing modalities that hold promise for improved long-term outcomes over conventional right ventricular pacing in patients requiring pacemaker therapy. However, implantation of CSP devices is limited to select centres in the United Kingdom (UK). Furthermore, there is little data, particularly in the UK, on short and long-term outcomes of CSP. Our centre established its CSP service in 2017. Here, we report procedural volumes and short- and long-term outcomes for patients undergoing CSP. Methods We performed a retrospective analysis of all CSP procedures performed at our centre between 1st March 2017 and 17th June 2022. Data on baseline demographics, procedure details, and clinical outcomes (acute procedural success, short-term [30-day] and long-term complications) were collected through review of contemporaneous patient records. Post-implant ECGs were retrospectively reviewed to determine successful CSP, defined in accordance with current clinical consensus. We included patients participating in research studies and those where coronary sinus lead implantation was attempted before converting to CSP. Four cases of left bundle branch-optimised cardiac resynchronisation therapy were excluded from this analysis. Results 317 HBP and LBBP procedures were performed over the course of the study period (table 1). Most devices were implanted for bradycardia pacing. Overall success rates were high for both HBP (191/258, 74%), and LBBP (48/59, 81%). Across all procedures, the median fluoroscopy time was 9.3 minutes (interquartile range 6.1–17.4; table 2), which was substantially shorter in those undergoing bradycardia pacing (figure 1). In those with successful CSP, the mean QRS duration was significantly shorter in the LBBP group post-implant (pre 137 ms±35, post 122 ms±24; p=0.02; figure 2A) and shorter, but not statistically significant, in the HBP group (pre 123 ms±33, post 118 ms±23; p=0.08). Left ventricular ejection fraction was significantly greater post-implant in both groups (HBP pre 40%±14; post 47%±13; p=0.008; LBBP pre 39%±13; post 48%±8; p=0.01; figure 2B). Short-term complications included nine (3%) lead displacements (of which three were His leads), two (1%) pneumothoraces, and one (0.3%) pocket haematoma. Two (0.6%) patients died within 30 days post-procedure. Over median post-implant follow-up of 3.2 years, rising His lead thresholds requiring re-intervention occurred in 27/222 (12%) patients with His leads. There were four (1%) device-related infections requiring extraction, which was feasible in all cases. Conclusion We describe our local experience with a large cohort of patients undergoing CSP over five years. Success rates of CSP implantation were high throughout this period, with associated improvements in ECG and echocardiographic parameters, and complication rates comparable to that reported in the literature. Conflict of Interest None
No takes yet. Share an insight, caveat, or question.
Tang et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: